Subscribe to our Newsletters !!
Infections pose an everpresent threat to society a
Biotech Fluidics has introduced a durable dual sta
A new COVID-19 variant, BA.3.2, informally called
The sustained tensions between Iran and the United
For a number of years now, healthcare systems glob
Tofu used to be associated with Asian cuisine, but
Dear Readers, Welcome to a fresh and forward-lo
Central Public Sector Undertaking Bengal Chemicals and Pharmaceuticals Limited (BCPL) on Friday (10 April) got leeway from sedate control specialists to make Hydroxychloroquine, which is being viewed as powerful in treating Covid-19 patients.
The organization got the permit days after the association government stepped up to the plate for enormous scope production of the medication taking into account the furious pandemic.
As indicated by the organization executive P.M. Chandraiya, BCPL has the ability to produce 10 lakh hydroxychloroquine tablets every day.
Established in 1901, BCPL is the nation’s first pharmaceutical organization, and once made Hydroychloroquine. In any case, it quit fabricating the item decades back.
Chandraiya said the expense of crude materials for making the medication has gone up multiple times in the previous scarcely any weeks.
“We have mentioned the association government to set a limit for the crude material costs,” he said.
